Galapagos, Merck in Potential ?170M Obesity, Diabetes Deal
TMCnet - The World's Largest Communications and Technology Community
TMC Launches New Sites ::  NGC  |  4GWE  |  Green Tech  |  Satellite  |  IT |  ITEXPO  |  Healthcare  |  Smart Grid  |  M2M  |  Smart Products  |  AstriCon News  |  SATCON News
TMCnet CHANNELS
#1 VoIP Enabler: Risk-free, Quick & Easy Deployment
Advanced Carrier Services
Appliance Deployment
ATCA
Auto Dialer
BPA (3rd Party Remote Call Monitoring)
Broadcast Modulator
Business Phone Systems
Business Process Automation
Business VoIP
Call Center
Call Center Certification
Call Center Digital Signage
Call Center Furniture
Call Center Hiring
Call Center Management
Call Center On Demand
Call Center Outsourcing
Call Center Scheduling
Call Center Software
Call Center Solutions
Call Center Training
Call Center Workforce Management
Call Monitoring
Call Recording
Communications Enabled Business Processes
Conference Call
Conferencing
Contact Center Headsets
Contact Center Software
CRM Software
CRM Solutions
DID/DDI
Digital Signage
e911
E911 Hosted Solutions
Email Archiving
Email Server
Enterprise Fax over IP
Enterprise VoIP
Ethernet Extender
Fax
Fax Over IP
FoIP
HD Conference
Hosted Contact Center
Hosted Exchange
Hosted PBX
Integrated Communications
IP Fax
IP Multimedia
IP Phone Maker
IP Phone System
IP Phones
IVR
Lead Management Software
Master Agent
Mobile Management
Mobile Unified Communications
Mobile Video
NEBS
Network Installation
Open Source CRM
PBX PCI Adapter
Phone Systems
Portable Satellite Antenna
Predictive Dialer
Sales Software
SATCON
SIP
Speech Recognition and Text to Speech
Telecom Cost Management
Telecom Expense Management
Telecom Lifecycle Management
Telecom Training
Telemarketing Software
Telepresence
Testing IP Services
Virtual Call Center
Virtual Office
Virtual PBX
Virtual Receptionist
Voice Broadcast
Voice Management
Voice Over IP
Voice Peering
Voicemail Replacement
VoIP Call Recording
VoIP Contact Center
VoIP Developer
VoIP Gateways
VoIP Monitoring
VoIPSwitch
Web Conferencing
Web Meeting
Wholesale VoIP
Wireless Expense Management
Wireless Management
Workforce Management
Workforce Optimization
Share
TMCnews
[January 09, 2009]

Galapagos, Merck in Potential ?170M Obesity, Diabetes Deal

(BioWorld Today Via Acquire Media NewsEdge) Mechelen, Belgium-based Galapagos NV signed its fifth major pharmaceutical alliance, inking a potential ?171.5 million (US$230.4 million)-plus deal with Merck & Co. Inc. to develop drugs aimed at the obesity and diabetes markets.



Under the terms, Galapagos will receive an up-front fee of ?1.5 million and will take on responsibility for the discovery and preclinical work on small-molecule candidates using its SilenceSelect discovery platform. Merck will retain the option to acquire an exclusive license to each drug candidate for further development and commercialization.

Galapagos is eligible for discovery, development and regulatory milestones that could exceed ?170 million total for multiple products, as well as specific sales milestones and royalties on any product sales.



It is the latest in a string of big pharma collaborations that Galapagos has secured in the last few years. The firm also boasts partnerships with GlaxoSmithKline plc for osteoarthritis drugs, with Eli Lilly and Co. for osteoporosis drugs and with German antibody firm Morphosys AG to target bone and joint diseases. And in 2007, the firm signed a potential ?1 billion partnership with Johnson & Johnson unit Janssen Pharmaceutical NV to develop rheumatoid arthritis drugs. (See BioWorld Today, June 8, 2006, Oct. 25, 2007, Dec. 20, 2007, and Dec. 1, 2008.)

Through those alliances, Galapagos is able to increase "our shots on goal," CEO Onno van de Stolpe said during a conference call. "We can have many more programs than we would be able to finance ourselves," and the company can see a number of its compounds "into the clinic in parallel."

The company reported a cash position of about ?25 million at midyear 2008, and said at the time that those funds should be sufficient for about 18 months. Galapagos has not yet reported its full-year 2008 results, but Van de Stolpe said the firm is projecting total revenues for the year to fall between ?75 million and ?80 million. n

?

?

Copyright ? 2009 Thomson BioWorld, All Rights Reserved.

[ Back To TMCnet.com's Homepage ]
Discussions:
Be the first to post a comment on this page!
 
By  
TMCnet
+ Add to the Discussion
Bookmark mobile.TMCnet.com on your mobile phone now to stay on top of the latest tech news.
TMCnet Videos
Featured White Papers
Featured White Paper RSS feed
10 reasons to switch to an IP PBX
Application Whitelisting: A new security paradigm
SCADA Systems Protection
view all white papers…
Top Stories
Today's TMCnet Top Stories and News Articles
Enterprise Fax Over IP: Mumbai International Airport Integrates Fax Se…
Arizona State Library Seeks $1.2 Million in Broadband Stimulus …
Comstor Singapore Picks #1 VoIP Enabler for Risk-free, Quick &…
Eight Tips to Improve Effectiveness of Call Center Digital Signage
Conferencing Feature: ROI Proves the Worth of Unified Communications
more of today's top stories...
Related VoIP News
Latest IP Communitions and VoIP News
SuperNet of Ohio Launches New Hosted VoIP Service for SMBs
Ronco Distributes Ascom's Wireless Communication Products
AudioCodes Intros MSBG PLUS an Open Platform for Unified Communications
New Vodafone 360 Samsung M1 Handset Built on LiMo Platform Brings Rich, Personalized Mobile Experience to Customers
Nortel Leverages Amazon EC2, Offers On-Demand Access to Cloud-Based Real-Time Applications

Today @ TMC
Subscribe FREE to all of TMC's monthly magazines. Click here now.